{"metadata": {"source": "erowid", "title": "Erowid LSD (Acid) Vault : FAQ", "description": "Frequently Asked Questions about LSD", "language": "No language found.", "url": "https://www.erowid.org/chemicals/lsd/lsd_faq.shtml", "drug": "LSD", "cid": 5761, "substance": "lsd", "category": "CHEMICALS", "erowid_column": "FAQ", "char_count": 70642, "word_count": 10952, "doc_id": "doc_156", "num_chunks": 103, "chunk_id": "156::chunk_10", "document_index": 156, "latency_s": 0.8448462999949697, "prompt_toks": 16280, "completion_toks": 61, "relevance_score": 1.154462e-06}, "content": "Drug: LSD | cid: 5761\nSource: erowid | Source description: Frequently Asked Questions about LSD\nErowid name: lsd\nCategory: CHEMICALS\nField: FAQ\n\n                    Text: \n                    A, Lucy in the sky with diamonds, Microdots, Mind detergent, Orange cubes, Orange micro, Owsley, Hits, Paper acid, Sacrament, Sandoz, Sugar, Sugar lumps, Sunshine, Tabs, Ticket, Twenty-five, Wedding bells, Windowpane, etc.\n\n\n                    Context: \n                    This excerpt lists common street slang terms and nicknames used to refer to LSD and its various forms, situated within a comprehensive FAQ and informational webpage about psychedelics, chemicals, and drug effects. It is relevant for identifying references to LSD in illegal contexts and understanding colloquial terminology associated with the substance.\n                "}
{"metadata": {"source": "psychonaut", "title": "MDMA - PsychonautWiki", "description": "3,4-Methylenedioxymethamphetamine (also known as ecstasy, E, XTC, emma, molly, mandy, pingers, and MDMA) is a classical entactogen substance of the amphetamine class. \nIt is the most well-known and widely-used member of the entactogens, a diverse group that includes MDA, methylone, 4-MMC, and 6-APB. It produces its effects by promoting the release of serotonin, dopamine, and norepinephrine in the brain, particularly serotonin.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/MDMA", "drug": "MDMA", "cid": 1615, "char_count": 74065, "word_count": 10533, "doc_id": "doc_82", "num_chunks": 98, "chunk_id": "82::chunk_40", "document_index": 82, "latency_s": 0.8365909999993164, "prompt_toks": 18749, "completion_toks": 71, "relevance_score": 7.112437e-07}, "content": "Drug: MDMA | cid: 1615\nSource: psychonaut | Source description: 3,4-Methylenedioxymethamphetamine (also known as ecstasy, E, XTC, emma, molly, mandy, pingers, and MDMA) is a classical entactogen substance of the amphetamine class. \nIt is the most well-known and widely-used member of the entactogens, a diverse group that includes MDA, methylone, 4-MMC, and 6-APB. It produces its effects by promoting the release of serotonin, dopamine, and norepinephrine in the brain, particularly serotonin.\n\n                    Text: \n                    Unity and interconnectedness - Experiences of lower-level unity and interconnectedness are commonly produced by MDMA, although in a much less abstract or ‘metaphysical’ form than compounds like LSD. This MDMA effect most consistently manifests itself within large crowds at raves and musical events in the form of \"becoming one with the crowd.\" Music is said to consistently intensify this effect as well and can be considered very memorable and a defining feature of the experience’s peak.\n\nAfter effects\n\n\n                    Context: \n                    This excerpt describes the transpersonal effect of MDMA related to unity and interconnectedness, emphasizing feelings of being \"one with the crowd\" during social or musical events. It highlights how music and large gatherings enhance this experience, making it a memorable peak effect and a key aspect of MDMA's subjective profile discussed within the broader effects and aftereffects sections of the document.\n                "}
{"metadata": {"source": "pubchem", "title": "Lysergide | C20H25N3O | CID 5761 - PubChem", "description": "Lysergide | C20H25N3O | CID 5761 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5761", "drug": "LSD", "cid": 5761, "char_count": 139518, "word_count": 18803, "doc_id": "doc_32", "num_chunks": 193, "chunk_id": "32::chunk_31", "document_index": 32, "latency_s": 1.3941526999988127, "prompt_toks": 36412, "completion_toks": 77, "relevance_score": 6.5779295e-07}, "content": "Drug: LSD | cid: 5761\nSource: pubchem | Source description: Lysergide | C20H25N3O | CID 5761 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    (77.8%) and a rise in quality of life (66.7%). Evaluations of subjective experiences suggest facilitated access to emotions, confrontation of previously unknown anxieties, worries, resources and intense emotional peak experiences a la Maslow as major psychological working mechanisms. The experiences created led to a restructuring of the person's emotional trust, situational understanding, habits and world view. LSD administered in a medically supervised psychotherapeutic setting can be safe and generate lasting benefits in patients with a life-threatening disease. Explanatory models for the therapeutic effects of LSD warrant further study.\n\n\n                    Context: \n                    This excerpt summarizes clinical research findings on LSD's therapeutic potential, highlighting sustained reductions in anxiety (77.8%) and improved quality of life (66.7%) in patients with life-threatening diseases. It discusses subjective experiences, psychological mechanisms, and the safety of supervised LSD administration, underscoring its relevance within the detailed pharmacological, safety, and clinical use sections of the full document.\n                "}
